The AIM-listed group has been given permission by US authorities to test an inhaler containing its drug ensifentrine on hospitalised coronavirus patients in Alabama.
MARKET REPORT: Fight to defeat Covid-19 boosts pharma minnow Verona
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]